Clinical Trials Directory

Trials / Conditions / Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8

Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8

19 registered clinical trials studyying Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 — 10 currently recruiting.

StatusTrialSponsorPhase
RecruitingTesting the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in P
NCT06364410
National Cancer Institute (NCI)Phase 1
RecruitingAdding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
NCT06203600
National Cancer Institute (NCI)Phase 2 / Phase 3
RecruitingCPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Pati
NCT05733000
Northwestern UniversityPhase 2
RecruitingPropranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Loca
NCT05651594
Roswell Park Cancer InstitutePhase 2
RecruitingmFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastati
NCT05677490
Alliance for Clinical Trials in OncologyPhase 3
RecruitingPersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Soli
NCT05269381
Mayo ClinicPhase 1 / Phase 2
RecruitingPembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adeno
NCT05041153
M.D. Anderson Cancer CenterEARLY_Phase 1
Active Not RecruitingTesting the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or
NCT04535401
National Cancer Institute (NCI)Phase 1
RecruitingTesting the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tu
NCT04704661
National Cancer Institute (NCI)Phase 1
RecruitingRamucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Adv
NCT04660760
Academic and Community Cancer Research UnitedPhase 2
Active Not RecruitingTesting the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Eso
NCT04460937
National Cancer Institute (NCI)Phase 1
RecruitingAvapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Sol
NCT04771520
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingBerzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gast
NCT03641313
National Cancer Institute (NCI)Phase 2
Active Not RecruitingNational Cancer Institute "Cancer Moonshot Biobank"
NCT04314401
National Cancer Institute (NCI)—
Active Not RecruitingPembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer
NCT04522336
M.D. Anderson Cancer CenterPhase 1
Active Not RecruitingSonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors
NCT04007744
Mayo ClinicPhase 1
Active Not RecruitingPaclitaxel for the Treatment of Gastric or Gastroesophageal Cancer
NCT04220827
M.D. Anderson Cancer CenterPhase 1
CompletedGenetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
NCT03707574
National Cancer Institute (NCI)—
CompletedIRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Ga
NCT03918499
City of Hope Medical CenterPhase 1 / Phase 2